Floatz logo

Warfarin

Cardiac Rhythm Disease

Massachusetts General HospitalSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cardiac Rhythm Disease cohort.

Asset / SponsorPhaseRating
Atropine
Medical University of Vienna
Phase 4BB
Flecainide
Assistance Publique - Hôpitaux de Paris
Phase 3B
Human Relaxin 1
Deeptankar DeMazumder
Phase 1/2CCC
Rocuronium Ion
4th Military Clinical Hospital with Polyclinic, Poland
N/AD
Propofol
4th Military Clinical Hospital with Polyclinic, Poland
N/AD

Same molecule, other indications

Warfarin is also rated in:

venous thromboembolismDormant
A
Indicative · Phase 4
81 / 100
View asset →
atrial fibrillationActive
BBB
Indicative · Phase 4
77 / 100
View asset →
hemorrhagic diseaseActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →